ETF model portfolios designed for real investor needs. Discover →
Invesco Dynamic Biotechnology & Genome ETF
PBE performance and flow charts
Performance
Flows
Historic performance and flows
Data as of September 10, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -0.70% | +12.83% | +14.59% | +35.63% | +57.51% | +23.66% |
| Flows | +$44M | +$117M | +$114M | +$113M | +$62M | +$64M |
Characteristics
The Invesco Dynamic Biotechnology & Genome ETF is built to track the Dynamic Biotech & Genome Intellidex TR Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | Invesco |
| N° of holdings | 30 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | June 23, 2005 |
| ESG | No |
More data and info about PBE on Trackinsight
Exposure
Data as of July 31, 2026Diversification
Total weight of top 15 holdings out of 30
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +19.58% | +19.33% | +20.48% | +22.57% |
Max drawdown | -5.73% | -11.70% | -22.21% | -33.32% |
Max drawdown duration | 7d | 166d | 324d | 1509d |
Time to recover | N/A | 88d | 177d | 1246d |
Replication quality
Data as of August 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is PBE?
PBE is a Passive ETF that provides exposure to Equity assets. It is managed by Invesco.
What index does PBE track?
PBE tracks the Dynamic Biotech & Genome Intellidex TR Index - USD, aiming to replicate its performance through full replication.
What does PBE invest in?
This ETF provides exposure to Equally Weighted US Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of PBE?
The total expense ratio (TER) of PBE is 0.59%, representing the annual fee charged by the fund manager.
When was PBE launched?
PBE was launched on June 23, 2005, marking its entry into the ETF market.
Who is the issuer of PBE?
PBE is issued by Invesco.
What is the AUM of PBE?
As of September 10, 2026, PBE manages $405.87 M, reflecting the total assets held in the fund.
How has PBE performed recently?
As of September 10, 2026, PBE delivered a return of -0.7% over the past month (1M performance), 12.83% over the past three months (3M), and 14.59% year-to-date (YTD).
What are the recent fund flows for PBE?
As of September 10, 2026, PBE has seen net flows of +$44M in the past month (1M flow) and +$114M year-to-date (YTD).
Does PBE pay dividends?
As of September 10, 2026, PBE has a trailing 12-month distribution yield of 1.66%.
How many holdings are in PBE
As of July 31, 2026, PBE holds 30 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is PBE?
As of July 31, 2026, PBE holds 30 securities, with 61.32% of its assets concentrated in its top 15 holdings.
What are the top holdings of PBE?
As of July 31, 2026, PBE holds a portfolio of 30 underlyings, with its largest positions including Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does PBE invest in?
As of July 31, 2026, PBE has its largest geographic exposures in USA.
What sectors or themes does PBE focus on?
As of July 31, 2026, PBE is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs September 8, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 31, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 24, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
What’sTheFund
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)
James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.
Browse all educational columns
Build and Analyze Your ETF Portfolio Like a Pro
Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.
